Table 1. Treatment groups
| Study Group | Treatment | Average Survival |
| 177Lu only | 300 µCi 177LuCl3 in PBS 1X | 13 ± 2.2 days |
| TRC105 only | 45 µg TRC105 in PBS 1X | 13.3 ± 1.9 days |
| 177Lu-DTPA-TRC105 low dose | 100 µCi 177Lu-DTPA-TRC105 + 30 µg TRC105 in PBS 1X (45 µg TRC105 total) | 14 ± 1.8 days |
| 177Lu-DTPA-TRC105 high dose | 300 µCi 177Lu-DTPA-TRC105 in PBS 1X (45 µg TRC105 total) | 32.4 ± 4.8 days |